, Tracking Stock Market Picks
Enter Symbol:
Chembio Diagnostics, Inc. (CEMI) [hlAlert]


Chembio Diagnostics (CEMI) rated Buy with price target $1 by Collins Stewart

Posted on: Friday,  Dec 21, 2007  11:25 AM ET by Collins Stewart

Chembio Diagnostics (CEMI) rated
Buy with price target $1 by Collins Stewart.

Chembio Diagnostics, Inc. develops, manufactures and markets rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company?s main products are four rapid tests for the detection of human immunodeficiency virus (HIV) antibodies. Three of these products employ lateral flow technology, can be used with all blood matrices as samples, and are manufactured in a standard cassette format, a dipstick format, and a barrel format. The tests employing the cassette and barrel formats were approved by the United States Food and Drug Administration (FDA) and are distributed by Inverness Medical Innovations, Inc. (Inverness) in the United States. Its fourth rapid HIV test, which is developed on its Dual Path Platform (DPP) technology, detects antibodies to HIV in oral fluid samples, as well as all blood matrices.

Collins Stewart's research department is built around a number of sector-specialist teams. Our analysts are leaders in their area of specialisation and combine deep industry knowledge with decades of stock broking experience to produce insightful, independent sector research. Our research approach encompasses Questâ„¢ principles and focuses on cash-driven valuation techniques. Research is a Collins Stewart cornerstone; it is leveraged throughout the organisation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/21/2007 11:25 AM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy